AR020317A1 - Derivados de acido carboxilico, composiciones farmaceuticas que los comprenden y sus usos, compuestos de acido carboxilico intermediario para la obtencionde dichos derivados y fragmento estructural comprendido por este. - Google Patents
Derivados de acido carboxilico, composiciones farmaceuticas que los comprenden y sus usos, compuestos de acido carboxilico intermediario para la obtencionde dichos derivados y fragmento estructural comprendido por este.Info
- Publication number
- AR020317A1 AR020317A1 ARP990100920A ARP990100920A AR020317A1 AR 020317 A1 AR020317 A1 AR 020317A1 AR P990100920 A ARP990100920 A AR P990100920A AR P990100920 A ARP990100920 A AR P990100920A AR 020317 A1 AR020317 A1 AR 020317A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- substituted
- hydrogen
- alkynyl
- alkenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19809144A DE19809144A1 (de) | 1998-03-04 | 1998-03-04 | Neue unsymmetrisch substituierte Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶LAMBDA¶/ET¶B¶-Rezeptorantagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR020317A1 true AR020317A1 (es) | 2002-05-08 |
Family
ID=7859627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990100920A AR020317A1 (es) | 1998-03-04 | 1999-03-04 | Derivados de acido carboxilico, composiciones farmaceuticas que los comprenden y sus usos, compuestos de acido carboxilico intermediario para la obtencionde dichos derivados y fragmento estructural comprendido por este. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1060167A1 (fr) |
| JP (1) | JP2002505324A (fr) |
| KR (1) | KR20010041537A (fr) |
| CN (1) | CN1292782A (fr) |
| AR (1) | AR020317A1 (fr) |
| AU (1) | AU2624799A (fr) |
| BG (1) | BG104754A (fr) |
| BR (1) | BR9908401A (fr) |
| CA (1) | CA2322541A1 (fr) |
| CO (1) | CO5080805A1 (fr) |
| DE (1) | DE19809144A1 (fr) |
| HR (1) | HRP20000650A2 (fr) |
| HU (1) | HUP0101173A3 (fr) |
| ID (1) | ID26183A (fr) |
| IL (1) | IL137537A0 (fr) |
| NO (1) | NO20004351L (fr) |
| PL (1) | PL342806A1 (fr) |
| SK (1) | SK11752000A3 (fr) |
| TR (1) | TR200002545T2 (fr) |
| TW (1) | TW509676B (fr) |
| WO (1) | WO1999044998A1 (fr) |
| ZA (1) | ZA991738B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19924892A1 (de) * | 1999-06-01 | 2000-12-07 | Basf Ag | Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
| AU7912600A (en) * | 1999-10-06 | 2001-05-10 | Basf Aktiengesellschaft | Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4411225A1 (de) * | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| DE19636046A1 (de) * | 1996-09-05 | 1998-03-12 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten |
-
1998
- 1998-03-04 DE DE19809144A patent/DE19809144A1/de not_active Withdrawn
-
1999
- 1999-02-25 ID IDW20001703A patent/ID26183A/id unknown
- 1999-02-25 HU HU0101173A patent/HUP0101173A3/hu unknown
- 1999-02-25 PL PL99342806A patent/PL342806A1/xx unknown
- 1999-02-25 CN CN998036315A patent/CN1292782A/zh active Pending
- 1999-02-25 EP EP99906251A patent/EP1060167A1/fr not_active Withdrawn
- 1999-02-25 SK SK1175-2000A patent/SK11752000A3/sk unknown
- 1999-02-25 CA CA002322541A patent/CA2322541A1/fr not_active Abandoned
- 1999-02-25 BR BR9908401-5A patent/BR9908401A/pt not_active IP Right Cessation
- 1999-02-25 KR KR1020007009714A patent/KR20010041537A/ko not_active Application Discontinuation
- 1999-02-25 AU AU26247/99A patent/AU2624799A/en not_active Abandoned
- 1999-02-25 WO PCT/EP1999/001208 patent/WO1999044998A1/fr not_active Application Discontinuation
- 1999-02-25 TR TR2000/02545T patent/TR200002545T2/xx unknown
- 1999-02-25 IL IL13753799A patent/IL137537A0/xx unknown
- 1999-02-25 JP JP2000534541A patent/JP2002505324A/ja active Pending
- 1999-03-04 AR ARP990100920A patent/AR020317A1/es not_active Application Discontinuation
- 1999-03-04 CO CO99013467A patent/CO5080805A1/es unknown
- 1999-03-04 TW TW088103317A patent/TW509676B/zh active
- 1999-03-04 ZA ZA9901738A patent/ZA991738B/xx unknown
-
2000
- 2000-09-01 NO NO20004351A patent/NO20004351L/no not_active Application Discontinuation
- 2000-09-07 BG BG104754A patent/BG104754A/xx unknown
- 2000-10-03 HR HR20000650A patent/HRP20000650A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20004351D0 (no) | 2000-09-01 |
| PL342806A1 (en) | 2001-07-02 |
| BG104754A (en) | 2001-05-31 |
| KR20010041537A (ko) | 2001-05-25 |
| AU2624799A (en) | 1999-09-20 |
| BR9908401A (pt) | 2000-10-31 |
| IL137537A0 (en) | 2001-07-24 |
| ID26183A (id) | 2000-12-07 |
| DE19809144A1 (de) | 1999-09-09 |
| TW509676B (en) | 2002-11-11 |
| CA2322541A1 (fr) | 1999-09-10 |
| TR200002545T2 (tr) | 2000-11-21 |
| CO5080805A1 (es) | 2001-09-25 |
| WO1999044998A1 (fr) | 1999-09-10 |
| NO20004351L (no) | 2000-09-01 |
| ZA991738B (en) | 2000-10-11 |
| SK11752000A3 (sk) | 2001-05-10 |
| EP1060167A1 (fr) | 2000-12-20 |
| JP2002505324A (ja) | 2002-02-19 |
| CN1292782A (zh) | 2001-04-25 |
| HRP20000650A2 (en) | 2001-06-30 |
| HUP0101173A2 (hu) | 2002-03-28 |
| HUP0101173A3 (en) | 2002-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9813686A (pt) | Composto, processo para produzi-lo, uso do mesmo, composição farmacêutica, e,processo para antagonizar o receptor de mcp-1. | |
| CY1105091T1 (el) | Αντικατεστημενες ενωσεις 2-αρυλοβενζαζολιου και η χρηση τους σαν παραγοντες κατα των ογκων | |
| AR006720A1 (es) | Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende | |
| CY1109886T1 (el) | Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες | |
| BRPI0606455A (pt) | compostos farmacêuticos | |
| HRP20010200B1 (en) | 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors | |
| ES2039242T3 (es) | Un procedimiento para la preparacion de nuevos derivados de piperidina. | |
| DK0790987T3 (da) | Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer | |
| CY1107468T1 (el) | Καρβαμιδικες ενωσεις για χρηση στην προληψη ή την αγωγη διαταραχων του αγχους | |
| CO4900070A1 (es) | NUEVOS DERIVADOS DE ACIDO CARBONICO, SU PRODUCCION Y APLICA- CION COMO ANTAGONISTAS MIXTOS DE RECEPTORES ET(sub A)/ET- (sub B) | |
| AR005419A1 (es) | Un compuesto derivado de piridinona, sus usos, un proceso para prepararlo, y una composicion farmaceutica que lo comprende | |
| ES2163417T3 (es) | Derivados de benzamida. | |
| AR246512A1 (es) | Procedimiento para la produccion de 2,2,6,6-tetraalquil-4-piperidilaminas. | |
| AR020317A1 (es) | Derivados de acido carboxilico, composiciones farmaceuticas que los comprenden y sus usos, compuestos de acido carboxilico intermediario para la obtencionde dichos derivados y fragmento estructural comprendido por este. | |
| BR9812892A (pt) | 2 4-diamino-1,3,5-triazinas substituìdas e seu emprego como herbicidas | |
| AR037125A1 (es) | Indoles sustituidos | |
| DE60131437D1 (de) | Neue 2-pyrimidinyloxy-n-arylbenzylaminderivate, deren verfahren und verwendungen | |
| CY1105695T1 (el) | Παραγωγα της εχινοκανδινης, μεθοδος παρασκευης τους και εφαρμογη τους σαν αντι-μυκητιασικα | |
| ES2055115T3 (es) | Derivados de fenil-amidina y fenil-guanidina sustituidos en posicion orto y agentes antidiabeticos y hipoglicemicos que los contienen. | |
| CY1107937T1 (el) | Προφαρμακα σε συνδετες υποδοχεα nmda | |
| CO4930270A1 (es) | Derivados heterociclicos de acido carbonico su produccion y aplicacion como antagonistas de receptores deendotelina | |
| AR017052A1 (es) | Derivados del acido carboxilico y su uso para preparar medicamentos. | |
| CO4950605A1 (es) | Nuevos derivados b-amino y b-azido de acido carbonico, su produccion y aplicacion como antagonistas de receptores de endotelina | |
| DK1257552T3 (da) | Xanthinderivater, mellemprodukter og anvendelse til behandling af osteoporose | |
| PE27099A1 (es) | Composiciones blanqueadoras |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |